CDMRP Prostate Cancer Research Program: Translational Science Award

The Translational Science Award mechanism supports translational research that will develop promising ideas in prostate cancer into clinical applications. Preliminary data to support the feasibility of the research hypotheses and research approaches are required.

FY23 PCRP Overarching Challenges:

• Improve quality of life to enhance outcomes and overall health and wellness for those impacted by prostate cancer
• Develop treatments or improve upon existing therapies to improve outcomes for men with lethal prostate cancer
• Advance health equity and reduce disparities in prostate cancer
• Define the biology of prostate cancer progression to lethal prostate cancer to reduce death

It is expected that 5 awards will be granted. 

Funding: $900,000 total  
Duration: 3 years

Research Authority due date: 27.7.23

Pre application (required) due date: 3.8.23

Full proposal due date: 24.8.23